Leber's Disease is a rare genetic eye condition. It causes sudden vision loss in one eye, often starting in your 20s or 30s. It leads to a blind spot in your vision and eventually blindness. It's inherited from your mother.
Every report comes from a Lived member, sent anonymously.
Have you tried Idebenone for Leber's Disease?
Leber's disease, known medically as Leber hereditary optic neuropathy (LHON), is an inherited condition that damages the optic nerve, the bundle of nerve fibers that carries visual signals from each eye to the brain. It causes painless loss of central vision, the sharp, detailed vision used for reading, driving and recognizing faces. Colors often look faded or washed out as well. LHON usually begins in the teens or twenties, although it can start in childhood or later in adult life, and it affects males much more often than females. Vision typically blurs or clouds in one eye first, and the other eye usually follows within weeks to a few months. A small number of people regain some central vision over time, but for most the loss is severe and lasting. Side vision is often partly preserved. In most people, vision loss is the only effect. A few families have a form called LHON plus, in which vision loss comes with tremor, other movement problems, heart rhythm disturbances or an illness resembling multiple sclerosis. LHON is a different disease from Leber congenital amaurosis, a retinal condition that causes severe vision loss in infancy, despite the similar name.
LHON is caused by a change in mitochondrial DNA. Mitochondria are the structures inside cells that turn food and oxygen into energy, and they carry a small set of their own genes. The changes behind LHON disrupt this energy production, and the nerve cells that form the optic nerve appear especially vulnerable. Three specific changes account for about 90% of cases, and which one a person carries affects how likely vision is to recover. Mitochondria are passed down only through the egg, so LHON is inherited from the mother. A woman who carries the change passes it to all of her children, whether or not she ever has symptoms herself. A man with LHON cannot pass it to his children. Many people with LHON have no known family history, partly because so many carriers never lose vision. Carrying the change does not mean vision loss is certain. More than half of male carriers and more than 85% of female carriers never develop symptoms, and it is not yet clear what tips some people into losing vision. Smoking and heavy drinking have been studied as possible contributors with conflicting results, but specialists advise carriers and people with LHON to avoid smoking and excessive alcohol.
Diagnosis usually starts with an eye specialist, often a neuro-ophthalmologist, who focuses on the connection between the eyes and the brain. Testing measures how clearly each eye sees and how well it detects color, and a visual field test maps where vision is missing. In LHON this typically shows a blind spot in the center of vision. Early on, the optic nerve at the back of the eye can look swollen even though it is not truly inflamed; over months it becomes pale as nerve fibers are lost. A scan called optical coherence tomography (OCT) measures the thickness of the nerve fiber layer and tracks these changes. Because LHON can resemble other causes of optic nerve damage, clinicians often order magnetic resonance imaging (MRI) of the brain and eye sockets and blood tests to rule out inflammation of the optic nerve (optic neuritis, which is usually painful), multiple sclerosis, a growth pressing on the nerve, vitamin deficiencies, toxins or infection. A genetic blood test confirms the diagnosis by finding one of the mitochondrial DNA changes linked to LHON. Knowing the specific change helps predict the likely course and guides advice for relatives.
No treatment reliably restores vision lost to LHON, but there are ways to give the best chance of improvement and to make daily life more manageable. Idebenone is an antioxidant drug designed to help mitochondria work and protect nerve cells from damage. In Europe it is approved as Raxone for people 12 and older with LHON. Its main 24-week trial did not meet its primary planned measure, but in further analyses people taking it read on average 3 to 6 more letters on an eye chart than those taking a placebo, and about 30% had a meaningful recovery of vision in at least one eye, compared with about 10% on placebo. Results vary considerably, and the evidence comes from small studies. Side effects are usually mild, most often cold-like symptoms, cough, diarrhea and back pain. The US Food and Drug Administration has not approved idebenone for LHON and has asked for more evidence, so in the US it is not an approved prescription medicine, and whether to use it and where it would come from should be discussed with a specialist. Gene therapy, which delivers a working copy of the affected gene into the eye by injection, has been tested mainly for the most common LHON change. It remains experimental, and clinical trials are the way to access it. Low-vision services can provide magnifiers, screen readers, high-contrast settings and training to use remaining side vision, and occupational rehabilitation can help with work and study. Genetic counseling helps the person and their mother's relatives understand who may carry the change.
LHON tends to move in two phases. In the first months, vision worsens in one eye and then the other. After that, vision usually settles at a lower level as the optic nerve thins. Most people are left with a large blind spot in the center of their vision while keeping some side vision, which allows many to move around on their own. Complete darkness is uncommon. The outlook depends partly on the specific genetic change. People with the change labeled m.14484T>C on a genetic test report have the best chance of some recovery, often months after vision reaches its lowest point, while recovery is least likely with the most common change, m.11778G>A. Recovery, when it happens, is usually partial. Adjusting to sudden vision loss as a young adult can affect education, work, driving and independence, and it can be emotionally hard. Low-vision tools, assistive technology and workplace adjustments help people keep studying, working and managing daily life with the vision they have. Follow-up with an eye specialist tracks vision over time and checks whether treatment is helping. Relatives on the mother's side who carry the change and have normal vision should know what early symptoms look like, and can ask an eye specialist whether periodic checks make sense for them.
While your vision is normal, arrange a visit with an eye specialist, and ask about genetic counseling, if LHON runs in your mother's family or if you are a woman who carries the change and is planning a family. Anyone with new, unexplained blurring, clouding or dimming of central vision, or colors that look faded, in either eye should see an ophthalmologist or neuro-ophthalmologist the same day, with or without a family history. This matters especially if LHON runs in your mother's family, you carry an LHON change, or LHON has already affected one eye. Early assessment confirms what is happening and allows treatment decisions while they may matter most. Tell your doctor promptly about palpitations, any fainting, tremor or new problems with movement or coordination, since a small number of people with LHON develop heart rhythm or nervous system problems as well.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Leber's Disease is like, what's helped you, or ask the community a question.